430 related articles for article (PubMed ID: 23337256)
1. Sex differences in the antidepressant-like effects of ketamine.
Carrier N; Kabbaj M
Neuropharmacology; 2013 Jul; 70():27-34. PubMed ID: 23337256
[TBL] [Abstract][Full Text] [Related]
2. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
[TBL] [Abstract][Full Text] [Related]
3. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
4. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ
Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM
Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985
[TBL] [Abstract][Full Text] [Related]
6. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
Suzuki K; Monteggia LM
Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
[TBL] [Abstract][Full Text] [Related]
7. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
[TBL] [Abstract][Full Text] [Related]
8. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
Engin E; Treit D; Dickson CT
Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of ketamine action as an antidepressant.
Zanos P; Gould TD
Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner.
Holubova K; Kleteckova L; Skurlova M; Ricny J; Stuchlik A; Vales K
Psychopharmacology (Berl); 2016 Jun; 233(11):2077-2097. PubMed ID: 27004790
[TBL] [Abstract][Full Text] [Related]
11. Tramadol pretreatment enhances ketamine-induced antidepressant effects and increases mammalian target of rapamycin in rat hippocampus and prefrontal cortex.
Yang C; Li WY; Yu HY; Gao ZQ; Liu XL; Zhou ZQ; Yang JJ
J Biomed Biotechnol; 2012; 2012():175619. PubMed ID: 22577289
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL/6 mice.
Dossat AM; Wright KN; Strong CE; Kabbaj M
Neuropharmacology; 2018 Mar; 130():30-41. PubMed ID: 29175352
[TBL] [Abstract][Full Text] [Related]
13. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
[TBL] [Abstract][Full Text] [Related]
14. Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.
Niciu MJ; Henter ID; Luckenbaugh DA; Zarate CA; Charney DS
Annu Rev Pharmacol Toxicol; 2014; 54():119-39. PubMed ID: 24392693
[TBL] [Abstract][Full Text] [Related]
15. Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine.
Carreno FR; Donegan JJ; Boley AM; Shah A; DeGuzman M; Frazer A; Lodge DJ
Mol Psychiatry; 2016 Sep; 21(9):1298-308. PubMed ID: 26619811
[TBL] [Abstract][Full Text] [Related]
16. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.
Liu RJ; Fuchikami M; Dwyer JM; Lepack AE; Duman RS; Aghajanian GK
Neuropsychopharmacology; 2013 Oct; 38(11):2268-77. PubMed ID: 23680942
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway.
Jett JD; Boley AM; Girotti M; Shah A; Lodge DJ; Morilak DA
Psychopharmacology (Berl); 2015 Sep; 232(17):3123-33. PubMed ID: 25986748
[TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibition and ketamine in rats: sex-differences in antidepressant-like efficacy.
Ledesma-Corvi S; Jornet-Plaza J; García-Fuster MJ
Biol Sex Differ; 2023 Oct; 14(1):73. PubMed ID: 37876000
[TBL] [Abstract][Full Text] [Related]
19. The role of mTOR in depression and antidepressant responses.
Abelaira HM; Réus GZ; Neotti MV; Quevedo J
Life Sci; 2014 Apr; 101(1-2):10-4. PubMed ID: 24582593
[TBL] [Abstract][Full Text] [Related]
20. Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms.
Wei IH; Chen KT; Tsai MH; Wu CH; Lane HY; Huang CC
J Agric Food Chem; 2017 Dec; 65(49):10792-10803. PubMed ID: 29161812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
